Membership
Tour
Register
Log in
Naked RNA Viruses
Follow
Industry
CPC
C12N2780/00
This industry / category may be too specific. Please go to a parent level for more data
Parent Industries
C
CHEMISTRY METALLURGY
C12
Biochemistry
C12N
MICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA
Current Industry
C12N2780/00
Naked RNA Viruses
Sub Industries
C12N2780/00011
Naked RNA Viruses
C12N2780/00021
Viruses as such
C12N2780/00022
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2780/00023
Virus like particles [VLP]
C12N2780/00031
Uses of virus other than therapeutic or vaccine
C12N2780/00032
Use of virus as therapeutic agent, other than vaccine
C12N2780/00033
Use of viral protein as therapeutic agent other than vaccine
C12N2780/00034
Use of virus or viral component as vaccine
C12N2780/00041
Use of virus, viral particle or viral elements as a vector
C12N2780/00042
virus or viral particle as vehicle
C12N2780/00043
viral genome or elements thereof as genetic vector
C12N2780/00044
Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2780/00045
Special targeting system for viral vectors
C12N2780/00051
Methods of production or purification of viral material
C12N2780/00052
relating to complementing cells and packaging systems for producing virus or viral particles
C12N2780/00061
Methods of inactivation or attenuation
C12N2780/00062
by genetic engineering
C12N2780/00063
by chemical treatment
C12N2780/00064
by serial passage
C12N2780/00071
Demonstrated in vivo effect
C12N2780/00088
For redistribution
C12N2780/10011
Narnaviridae
C12N2780/10021
Viruses as such
C12N2780/10022
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2780/10023
Virus like particles [VLP]
C12N2780/10031
Uses of virus other than therapeutic or vaccine
C12N2780/10032
Use of virus as therapeutic agent, other than vaccine
C12N2780/10033
Use of viral protein as therapeutic agent other than vaccine
C12N2780/10034
Use of virus or viral component as vaccine
C12N2780/10041
Use of virus, viral particle or viral elements as a vector
C12N2780/10042
virus or viral particle as vehicle
C12N2780/10043
viral genome or elements thereof as genetic vector
C12N2780/10044
Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2780/10045
Special targeting system for viral vectors
C12N2780/10051
Methods of production or purification of viral material
C12N2780/10052
relating to complementing cells and packaging systems for producing virus or viral particles
C12N2780/10061
Methods of inactivation or attenuation
C12N2780/10062
by genetic engineering
C12N2780/10063
by chemical treatment
C12N2780/10064
by serial passage
C12N2780/10071
Demonstrated in vivo effect
C12N2780/10088
For redistribution
Industries
Overview
Organizations
People
Information
Impact
Please log in for detailed analytics